VivoSim Labs, Inc. Form DEFR14A: Revised definitive proxy materials
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2022-09-22: Form DEFR14A; Description DEFR14A; Document onvo-defr14a_20221012.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2022-09-22 | DEFR14A | DEFR14A | onvo-defr14a_20221012.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |